CongressBuys

Rep. Josh Gottheimer sold BioCryst Pharmaceuticals (BCRX)

Rep. Josh Gottheimer (D-NJ-5) · $1K–$15K · traded Sep 15, 2023

Transaction
Sold (full)
Amount
$1K–$15K
Owner
Joint
Traded
Sep 15, 2023
Disclosed
Oct 15, 2023
Days to disclose
30
Asset type
Stock
As filed
BioCryst Pharmaceuticals, Inc.
Industry
Biotechnology · Healthcare

Other trades in this filing

All of Gottheimer's trades →

Recent Congress trades in BCRX

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.